David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 15,000 shares at $55.78 ($837K) on 2014-11-28, disclosed to the SEC on 2014-12-02.
Scheduled sale ($837k) by EVP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.23 | 5,000 | $276K | 33.0% |
| 2 | $55.78 | 5,000 | $279K | 33.3% |
| 3 | $56.34 | 5,000 | $282K | 33.7% |
| Total | $55.78 avg | 15,000 | $837K | 100% |
| Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |
| CPHD | SELL | 2014-10-31 | $1.1M | — | Filing → |